WO2005003177A3 - Molecules pour le ciblage et l’assemblage in situ de proteines therapeutiques et leur utilisation - Google Patents
Molecules pour le ciblage et l’assemblage in situ de proteines therapeutiques et leur utilisation Download PDFInfo
- Publication number
- WO2005003177A3 WO2005003177A3 PCT/FR2004/001436 FR2004001436W WO2005003177A3 WO 2005003177 A3 WO2005003177 A3 WO 2005003177A3 FR 2004001436 W FR2004001436 W FR 2004001436W WO 2005003177 A3 WO2005003177 A3 WO 2005003177A3
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- segment
- molecules
- therapeutic
- targeting
- oligomerisation
- Prior art date
Links
- 230000001225 therapeutic effect Effects 0.000 title abstract 6
- 230000008685 targeting Effects 0.000 title abstract 4
- 238000011065 in-situ storage Methods 0.000 title abstract 2
- 102000004169 proteins and genes Human genes 0.000 title 1
- 108090000623 proteins and genes Proteins 0.000 title 1
- 150000001875 compounds Chemical class 0.000 abstract 2
- 206010061218 Inflammation Diseases 0.000 abstract 1
- 241000124008 Mammalia Species 0.000 abstract 1
- 206010028980 Neoplasm Diseases 0.000 abstract 1
- 230000005775 apoptotic pathway Effects 0.000 abstract 1
- 230000015572 biosynthetic process Effects 0.000 abstract 1
- 230000004054 inflammatory process Effects 0.000 abstract 1
- 239000000543 intermediate Substances 0.000 abstract 1
- 239000000203 mixture Substances 0.000 abstract 1
- 230000001575 pathological effect Effects 0.000 abstract 1
- 230000007170 pathology Effects 0.000 abstract 1
- 239000008194 pharmaceutical composition Substances 0.000 abstract 1
- 238000002360 preparation method Methods 0.000 abstract 1
- 238000003786 synthesis reaction Methods 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/745—Blood coagulation or fibrinolysis factors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
- C07K14/715—Receptors; Cell surface antigens; Cell surface determinants for cytokines; for lymphokines; for interferons
- C07K14/7151—Receptors; Cell surface antigens; Cell surface determinants for cytokines; for lymphokines; for interferons for tumor necrosis factor [TNF], for lymphotoxin [LT]
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/745—Blood coagulation or fibrinolysis factors
- C07K14/755—Factors VIII, e.g. factor VIII C (AHF), factor VIII Ag (VWF)
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/775—Apolipopeptides
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K19/00—Hybrid peptides, i.e. peptides covalently bound to nucleic acids, or non-covalently bound protein-protein complexes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Biochemistry (AREA)
- Molecular Biology (AREA)
- Genetics & Genomics (AREA)
- Biophysics (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Toxicology (AREA)
- Gastroenterology & Hepatology (AREA)
- Zoology (AREA)
- Pharmacology & Pharmacy (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Hematology (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Cell Biology (AREA)
- Immunology (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicinal Preparation (AREA)
Abstract
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR0307164A FR2856070A1 (fr) | 2003-06-13 | 2003-06-13 | Molecules pour le ciblage et l'assemblage in situ de proteines therapeutiques et leur utilisation |
FR03/07164 | 2003-06-13 |
Publications (2)
Publication Number | Publication Date |
---|---|
WO2005003177A2 WO2005003177A2 (fr) | 2005-01-13 |
WO2005003177A3 true WO2005003177A3 (fr) | 2006-05-11 |
Family
ID=33484430
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/FR2004/001436 WO2005003177A2 (fr) | 2003-06-13 | 2004-06-09 | Molecules pour le ciblage et l’assemblage in situ de proteines therapeutiques et leur utilisation |
Country Status (2)
Country | Link |
---|---|
FR (1) | FR2856070A1 (fr) |
WO (1) | WO2005003177A2 (fr) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US8734795B2 (en) | 2008-10-31 | 2014-05-27 | Biogen Idec Ma Inc. | Light targeting molecules and uses thereof |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2007110001A2 (fr) * | 2006-03-29 | 2007-10-04 | Centro De Ingenieria Genetica Y Biotecnologia | Molécules chimériques fusionnées à la matriline-1, à usage thérapeutique |
FR3025374B1 (fr) | 2014-09-01 | 2018-03-09 | Valeo Equipements Electriques Moteur | Relais statique de commande d'un demarreur electrique de vehicule automobile et demarreur electrique de vehicule automobile correspondant |
Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1996037621A2 (fr) * | 1995-05-23 | 1996-11-28 | Morphosys Gesellschaft Für Proteinoptimierung Mbh | Proteines multimeres |
WO2000020453A1 (fr) * | 1998-10-02 | 2000-04-13 | Commissariat A L'energie Atomique | Structure chimique ayant une affinite pour un phospholipide, et compose de marquage, trousse de diagnostic, et medicament comprenant cette structure |
WO2002022680A2 (fr) * | 2000-09-15 | 2002-03-21 | Klaus Pfizenmaier | Activation localement specifique, par l'intermediaire d'anticorps, d'une zytokine pro-apoptose : amaize (antibody-mediated apoptosis inducing zytokine) |
WO2002087498A2 (fr) * | 2001-04-26 | 2002-11-07 | Board Of Regents, The University Of Texas System | Compositions d'imagerie diagnostique, leurs methodes de synthese et utilisation |
FR2841557A1 (fr) * | 2002-07-01 | 2004-01-02 | Commissariat Energie Atomique | Peptides ayant une affinite pour un phospholipide et utilisations |
-
2003
- 2003-06-13 FR FR0307164A patent/FR2856070A1/fr active Pending
-
2004
- 2004-06-09 WO PCT/FR2004/001436 patent/WO2005003177A2/fr active Application Filing
Patent Citations (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1996037621A2 (fr) * | 1995-05-23 | 1996-11-28 | Morphosys Gesellschaft Für Proteinoptimierung Mbh | Proteines multimeres |
WO2000020453A1 (fr) * | 1998-10-02 | 2000-04-13 | Commissariat A L'energie Atomique | Structure chimique ayant une affinite pour un phospholipide, et compose de marquage, trousse de diagnostic, et medicament comprenant cette structure |
WO2002022680A2 (fr) * | 2000-09-15 | 2002-03-21 | Klaus Pfizenmaier | Activation localement specifique, par l'intermediaire d'anticorps, d'une zytokine pro-apoptose : amaize (antibody-mediated apoptosis inducing zytokine) |
US20040033511A1 (en) * | 2000-09-15 | 2004-02-19 | Klaus Pfizenmaier | Site-specific antibody-mediated activation of proapoptotic cytokines: AMAIZEe (antibody-mediated apoptosis inducing cytokines) |
WO2002087498A2 (fr) * | 2001-04-26 | 2002-11-07 | Board Of Regents, The University Of Texas System | Compositions d'imagerie diagnostique, leurs methodes de synthese et utilisation |
FR2841557A1 (fr) * | 2002-07-01 | 2004-01-02 | Commissariat Energie Atomique | Peptides ayant une affinite pour un phospholipide et utilisations |
Non-Patent Citations (7)
Title |
---|
DILLON S R ET AL: "Annexin V binds to positively selected B cells", JOURNAL OF IMMUNOLOGY, THE WILLIAMS AND WILKINS CO. BALTIMORE, US, vol. 166, no. 1, 1 January 2001 (2001-01-01), pages 58 - 71, XP002271951, ISSN: 0022-1767 * |
FADOK V A ET AL: "THE ROLE OF PHOSPHATIDYLSERINE IN RECOGNITION OF APOPTOTIC CELLS BY PHAGOCYTES", CELL DEATH AND DIFFERENTIATION, EDWARD ARNOLD, OXFORD, GB, vol. 5, no. 7, July 1998 (1998-07-01), pages 551 - 562, XP009026519, ISSN: 1350-9047 * |
OKABAYASHI K ET AL: "Secretory production of recombinant urokinase-type plasminogen activator-annexin V chimeras in Pichia pastoris", GENE: AN INTERNATIONAL JOURNAL ON GENES AND GENOMES, ELSEVIER, AMSTERDAM, NL, vol. 177, no. 1, 24 October 1996 (1996-10-24), pages 69 - 76, XP004043376, ISSN: 0378-1119 * |
RAYNAL P ET AL: "ANNEXINS: THE PROBLEM OF ASSESSING THE BIOLOGICAL ROLE FOR A GENE FAMILY OF MULTIFUNCTIONAL CALCIUM- AND PHOSPHOLIPID-BINDING PROTEINS", BIOCHIMICA ET BIOPHYSICA ACTA. MR. REVIEWS ON BIOMEMBRANES, ELSEVIER, AMSTERDAM, NL, vol. 1197, 1994, pages 63 - 93, XP002932761, ISSN: 0304-4157 * |
SMITH PAUL D ET AL: "Structural evolution of the annexin supergene family", TRENDS IN GENETICS, vol. 10, no. 7, 1994, pages 241 - 245, XP009061159, ISSN: 0168-9525 * |
TAIT J F ET AL: "PROUROKINASE-ANNEXIN V CHIMERAS", JOURNAL OF BIOLOGICAL CHEMISTRY, AMERICAN SOCIETY OF BIOLOCHEMICAL BIOLOGISTS, BIRMINGHAM,, US, vol. 270, no. 37, 15 September 1995 (1995-09-15), pages 21594 - 21599, XP002920655, ISSN: 0021-9258 * |
VAN ENGELAND MANON ET AL: "Annexin V-affinity assay: A review on an apoptosis detection system based on phosphatidylserine exposure", CYTOMETRY, vol. 31, no. 1, January 1998 (1998-01-01), pages 1 - 9, XP009026520, ISSN: 0196-4763 * |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US8734795B2 (en) | 2008-10-31 | 2014-05-27 | Biogen Idec Ma Inc. | Light targeting molecules and uses thereof |
Also Published As
Publication number | Publication date |
---|---|
FR2856070A1 (fr) | 2004-12-17 |
WO2005003177A2 (fr) | 2005-01-13 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
WO2007127474A3 (fr) | Compositions et traitements utilisant des pyridazines et des inhibiteurs de cholinestérase | |
WO2008085794A3 (fr) | Méthodes et compositions associées à des composés adhérant aux caillots | |
WO2007076055A3 (fr) | Compositions et methodes comprenant l'utilisation d'antagonistes du recepteur active par des proteases | |
WO2008130320A3 (fr) | Nouveaux composés 806 | |
WO2006023844A3 (fr) | Compositions et procedes comportant des antagonistes de recepteur active par la proteinase | |
MY147647A (en) | Imidazo [1,2-a] pyridine derivatives : preparation and pharmaceutical applications | |
EP2535355A3 (fr) | Anticorps diriges contre CD38 pour le traitement du myelome multiple | |
WO2006050389A3 (fr) | Composes pyridazine, compositions et procedes associes | |
WO2007130383A3 (fr) | Compositions et traitements utilisant des pyridazines et des secrétases | |
WO2004074434A3 (fr) | Methodes et compositions permettant d'administrer des agents therapeutiques et diagnostiques | |
WO2006058867A3 (fr) | Pteridines substituees pour le traitement de maladies inflammatoires | |
WO2006014678A3 (fr) | Compositions et methodes d'utilisation de la proteine 4 analogue a l'angiopoietine | |
WO2008074997A8 (fr) | Benzamides de pyridine et benzamides de pyrazine utilisés en tant qu'inhibiteurs de la pkd | |
WO2007010401A3 (fr) | Il-7 glycosylee, preparation et utilisations | |
WO2005019258A3 (fr) | Compositions et methodes de traitement de maladies relatives au systeme immunitaire | |
WO2001001748A3 (fr) | Composés se liant à her2 | |
WO2008142164A3 (fr) | Séquences d'acides aminés dirigées contre rank-l et polypeptides comprenant ces dernières, destinés au traitement de maladies et affections osseuses | |
IL171914A0 (en) | Variants of il-18bp, their preparation and pharmaceutical compositions containing them | |
PL2233127T3 (pl) | Zastosowanie przeciwutleniaczy do wytwarzania kompozycji farmaceutycznej lub kosmetycznej do ochrony skóry przed uszkodzeniem wywołanym przez promieniowanie podczerwone | |
WO2005051914A8 (fr) | Inhibiteurs de benzylether et benzylamino de beta-secretase pour traiter la maladie d'alzheimer | |
WO2004074243A3 (fr) | Heterocyclyl-3-sulfonylindazoles utilises comme ligands de la 5-hydroxytryptamine-6 | |
SI2233127T1 (sl) | Uporaba antioksidantov za pripravo farmacevtskega ali kozmetičnega sestavka za zaščito kože pred poškodbo z infrardečim sevanjem | |
NO330984B1 (no) | Aminosyre-fenoksyestere, fremgangsmate for fremstilling av slike, mellomprodukter i synteseveien, farmasoytisk preparat omfattende slike samt anvendelse av slike for fremstilling av farmasoytisk preparat for behandling av sykdom | |
WO2007135026A3 (fr) | Ptéridines substituées | |
WO1999009000A3 (fr) | Nouveaux inhibiteurs de l'aggrecanase et des metalloproteinases matricielles pour le traitement de l'arthrite |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AK | Designated states |
Kind code of ref document: A2 Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BW BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE EG ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NA NI NO NZ OM PG PH PL PT RO RU SC SD SE SG SK SL SY TJ TM TN TR TT TZ UA UG US UZ VC VN YU ZA ZM ZW |
|
AL | Designated countries for regional patents |
Kind code of ref document: A2 Designated state(s): BW GH GM KE LS MW MZ NA SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IT LU MC NL PL PT RO SE SI SK TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG |
|
121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
32PN | Ep: public notification in the ep bulletin as address of the adressee cannot be established |
Free format text: CONSTATATION DE LA PERTE D UN DROIT CONFORMEMENT A LA REGLE 69(1) CPE (OEB FORM 1205A, DATE: 16-03-2006) |
|
122 | Ep: pct application non-entry in european phase |